Your browser doesn't support javascript.
loading
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
Monk, Bradley J; Grisham, Rachel N; Banerjee, Susana; Kalbacher, Elsa; Mirza, Mansoor Raza; Romero, Ignacio; Vuylsteke, Peter; Coleman, Robert L; Hilpert, Felix; Oza, Amit M; Westermann, Anneke; Oehler, Martin K; Pignata, Sandro; Aghajanian, Carol; Colombo, Nicoletta; Drill, Esther; Cibula, David; Moore, Kathleen N; Christy-Bittel, Janna; Del Campo, Josep M; Berger, Regina; Marth, Christian; Sehouli, Jalid; O'Malley, David M; Churruca, Cristina; Boyd, Adam P; Kristensen, Gunnar; Clamp, Andrew; Ray-Coquard, Isabelle; Vergote, Ignace.
Afiliación
  • Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ.
  • Grisham RN; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY.
  • Banerjee S; Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Kalbacher E; Centre Hospitalier Régional et Universitaire de Besançon, CHRU de Besançon, Besançon, France.
  • Mirza MR; Nordic Society of Gynaecological Oncology and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Romero I; Servicio de Oncologia Medica, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
  • Vuylsteke P; CHU Université catholique de Louvain Namur, Sainte-Elisabeth, Namur, Belgium.
  • Coleman RL; University of Botswana, Gaborone, Botswana.
  • Hilpert F; MD Anderson Cancer Center, Houston, TX.
  • Oza AM; Onkologisches Therapiezentrum am Krankenhaus Jerusalem, Hamburg, Germany.
  • Westermann A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Oehler MK; Dutch Gynaecological Oncology Group, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Pignata S; Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, South Australia 5005, Australia.
  • Aghajanian C; Istituto Nazionale Tumori Fondazione Pascale IRCCS, Naples, Italy.
  • Colombo N; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ.
  • Drill E; Dipartimento Medicina e Chirurgia, Università Milano-Bicocca, Programma Ginecologia Oncologica Istituto Europeo Oncologia, IRCCS, Milan, Italy.
  • Cibula D; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY.
  • Moore KN; First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Christy-Bittel J; Stephenson Cancer Center at The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Del Campo JM; Pfizer, New York, NY.
  • Berger R; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Marth C; University Clinic for Gynaecology and Obstetrics, Medical University of Innsbruck, Innsbruck 6020, Austria.
  • Sehouli J; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austrian AGO, Innsbruck, Austria.
  • O'Malley DM; Center for Oncological Surgery, European Competence Center for Ovarian Cancer Campus Virchow Klinikum and Benjamin Franklin Charité Comprehensive Cancer Center , Medical University of Berlin, Berlin, Germany.
  • Churruca C; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH.
  • Boyd AP; Biodonostia HRI, Osasun Ikerketa Insitutua, Insituto de Investigacion Sanitaria, San Sebastián, Gipuzkoa, Spain.
  • Kristensen G; Pfizer, New York, NY.
  • Clamp A; Department for Gynecologic Oncology and Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
  • Ray-Coquard I; Department of Medical Oncology, The Christie National Health Service Foundation Trust, and University of Manchester, Manchester, United Kingdom.
  • Vergote I; Centre Léon Bérard, Netsarc Network, Université Claude Bernard Lyon 1, Lyon, France.
J Clin Oncol ; 38(32): 3753-3762, 2020 11 10.
Article en En | MEDLINE | ID: mdl-32822286
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Bencimidazoles / Cistadenocarcinoma Seroso / Inhibidores de Proteínas Quinasas / Neoplasias de las Trompas Uterinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Azerbaiyán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Bencimidazoles / Cistadenocarcinoma Seroso / Inhibidores de Proteínas Quinasas / Neoplasias de las Trompas Uterinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Azerbaiyán